Skip to main content
. 2022 Jun 20;35(1):ivac167. doi: 10.1093/icvts/ivac167

Figure 3:

Figure 3:

(a) Disease-free survival in the 2 group of patients. (b) Thymoma-related survival in the 2 groups of patients.